A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Acute Leukemia · Lymphoblastic Leukemia · Lymphoblastic Lymphoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois, United States
University of Rochester Medical Center, Wilmot Cancer Center, Rochester, New York, United States
Contact: Study coordinator (Wilmot Cancer Center Clinical Trials Office) · wcictoresearch@urmc.rochester.edu · 585-275-5863Contact: Principal Investigator (Kristen O'Dwyer, MD)